Clinical Trial Update: Early High-Dose Vitamin D and Residual β-Cell Function in Pediatric Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial investigating early high-dose vitamin D and residual beta-cell function in pediatric Type 1 Diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Type 1 Diabetes | Phase 3 | Status: UNKNOWN